Perceived need for care and stigma experiences among individuals with methamphetamine-related admissions to inpatient mental health wards.
Canada
Methamphetamine
Perceived need
Stigma
Journal
Harm reduction journal
ISSN: 1477-7517
Titre abrégé: Harm Reduct J
Pays: England
ID NLM: 101153624
Informations de publication
Date de publication:
02 08 2023
02 08 2023
Historique:
received:
06
02
2023
accepted:
16
07
2023
medline:
4
8
2023
pubmed:
3
8
2023
entrez:
2
8
2023
Statut:
epublish
Résumé
There are gaps in our understanding of treatment needs among people who use methamphetamine. We examined the demographics, perceived treatment needs, barriers to accessing care, and stigma experienced by an inpatient sample of people who use methamphetamine. This study surveyed a convenience sample of patients admitted to psychiatry wards with a history of methamphetamine use in Winnipeg, Canada, between May 1 and July 31, 2019. The Perceived Need for Care Questionnaire (PNCQ-9) was used to assess treatment needs and barriers to care, and the Substance Use Stigma Mechanisms Scale (SU-SMS) was used to assess enacted, anticipated, and internalized stigma. Prevalence rates of perceived need, stigma, and demographic variables were determined. A total of 103 potential participants were identified, with 34 completing the survey. The most common age group was 21-30 years of age (41.2%); an approximate equal number of men and women; and almost all were single and never married (91.1%). Rates of perceived need for care were very high across all treatment types, including 91% identifying a need for medication treatment for their mental health or substance use. Despite the majority receiving care across the seven types of care described in the PNCQ-9, most felt they did not receive enough care. Unmet need for care was therefore high in many categories, including rates of 87% for counselling and skills training. The most common barriers to having needs met were a desire to self-manage substance use, and not receiving care after asking for help. Almost all participants reported experiencing stigma (94%). Stigma from family was endorsed significantly more than stigma from health care providers (p = 0.005). The average hospitalized person who uses methamphetamine in this sample is young, single, and has not completed any post-secondary education. High rates of perceived treatment need suggest an awareness of problems with methamphetamine, yet most interventions are perceived as inadequate. People who used methamphetamine felt highly stigmatized, particularly by their family members. Trial registration Registered with the Health Research Ethics Board at the University of Manitoba (Number HS22605 (H2019:072), renewed February 14, 2022).
Sections du résumé
BACKGROUND
There are gaps in our understanding of treatment needs among people who use methamphetamine. We examined the demographics, perceived treatment needs, barriers to accessing care, and stigma experienced by an inpatient sample of people who use methamphetamine.
METHODS
This study surveyed a convenience sample of patients admitted to psychiatry wards with a history of methamphetamine use in Winnipeg, Canada, between May 1 and July 31, 2019. The Perceived Need for Care Questionnaire (PNCQ-9) was used to assess treatment needs and barriers to care, and the Substance Use Stigma Mechanisms Scale (SU-SMS) was used to assess enacted, anticipated, and internalized stigma. Prevalence rates of perceived need, stigma, and demographic variables were determined.
RESULTS
A total of 103 potential participants were identified, with 34 completing the survey. The most common age group was 21-30 years of age (41.2%); an approximate equal number of men and women; and almost all were single and never married (91.1%). Rates of perceived need for care were very high across all treatment types, including 91% identifying a need for medication treatment for their mental health or substance use. Despite the majority receiving care across the seven types of care described in the PNCQ-9, most felt they did not receive enough care. Unmet need for care was therefore high in many categories, including rates of 87% for counselling and skills training. The most common barriers to having needs met were a desire to self-manage substance use, and not receiving care after asking for help. Almost all participants reported experiencing stigma (94%). Stigma from family was endorsed significantly more than stigma from health care providers (p = 0.005).
CONCLUSIONS
The average hospitalized person who uses methamphetamine in this sample is young, single, and has not completed any post-secondary education. High rates of perceived treatment need suggest an awareness of problems with methamphetamine, yet most interventions are perceived as inadequate. People who used methamphetamine felt highly stigmatized, particularly by their family members. Trial registration Registered with the Health Research Ethics Board at the University of Manitoba (Number HS22605 (H2019:072), renewed February 14, 2022).
Identifiants
pubmed: 37533062
doi: 10.1186/s12954-023-00827-5
pii: 10.1186/s12954-023-00827-5
pmc: PMC10399029
doi:
Substances chimiques
Methamphetamine
44RAL3456C
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
104Subventions
Organisme : CIHR
Pays : Canada
Informations de copyright
© 2023. The Author(s).
Références
Subst Abuse Treat Prev Policy. 2021 Sep 16;16(1):68
pubmed: 34530878
Psychiatry Res. 2018 Oct;268:189-192
pubmed: 30041133
Drug Alcohol Depend. 2014 Oct 1;143:11-21
pubmed: 25176528
Harm Reduct J. 2022 Feb 9;19(1):14
pubmed: 35139877
CNS Drugs. 2014 Dec;28(12):1115-26
pubmed: 25373627
BMC Psychiatry. 2012 Dec 05;12:221
pubmed: 23216941
J Addict Dis. 2015;34(1):88-100
pubmed: 25415384
Soc Work Public Health. 2013;28(2):109-18
pubmed: 23461346
Asian J Psychiatr. 2016 Aug;22:162-6
pubmed: 27520922
Drug Alcohol Depend. 2013 Jan 1;127(1-3):59-64
pubmed: 22770461
Arch Gen Psychiatry. 2007 Jul;64(7):843-52
pubmed: 17606818
Health Soc Care Community. 2022 Sep;30(5):1619-1636
pubmed: 35032080
Drug Alcohol Rev. 2017 May;36(3):295-304
pubmed: 27242102
AIDS Care. 2014 Jan;26(1):1-11
pubmed: 23767772
Can J Psychiatry. 2005 Oct;50(12):753-61
pubmed: 16408523
Aust N Z J Psychiatry. 2009 Jul;43(7):624-34
pubmed: 19530019
Can J Psychiatry. 2017 Aug;62(8):551-559
pubmed: 28616935
Soc Sci Med. 2012 May;74(10):1494-503
pubmed: 22444459
Addiction. 2012 Jan;107(1):39-50
pubmed: 21815959
Int J Drug Policy. 2021 Jan;87:102982
pubmed: 33126164
Drug Alcohol Depend. 2016 Nov 01;168:263-273
pubmed: 27736680
Drug Alcohol Depend. 2013 Jul 1;131(1-2):23-35
pubmed: 23490450
Int J Drug Policy. 2018 Jul;57:104-110
pubmed: 29715589
Harm Reduct J. 2017 Jun 5;14(1):32
pubmed: 28583121
Drug Alcohol Depend. 2016 May 1;162:34-43
pubmed: 26972790
Soc Sci Med. 2014 Mar;105:59-66
pubmed: 24508718
Drug Alcohol Rev. 2006 Nov;25(6):611-24
pubmed: 17132577
Psychopharmacology (Berl). 2020 Aug;237(8):2233-2255
pubmed: 32601988
Soc Psychiatry Psychiatr Epidemiol. 2000 Sep;35(9):427-35
pubmed: 11089671
Drug Alcohol Depend. 2014 Jun 1;139:18-25
pubmed: 24685563
Drug Alcohol Depend. 2022 Oct 1;239:109608
pubmed: 36063622
Psychiatr Serv. 2009 Jul;60(7):943-9
pubmed: 19564225